echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > FDA accelerates approval of Chelsea medical's Northern

    FDA accelerates approval of Chelsea medical's Northern

    • Last Update: 2014-02-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: China Council for the promotion of drugs 2014-02-19 February 18, 2014, Chelsea International Medical Co., Ltd., a US pharmaceutical company, said that the US Food and drug administration has accelerated the approval of northern a for the treatment of neurogenic orthostatic hypotension (Noh) Northern is the first and only FDA approved drug to improve the symptoms of neurogenic orthostatic hypotension Northern A is suitable for the treatment of adult Noh patients with vertigo, blurred vision or "dark feeling in front of eyes" caused by primary autonomic nervous failure, dopamine β - hydroxylase deficiency and non diabetic autonomic neuropathy Noh is a disorder of autonomic nervous system caused by the secretion or release of noradrenaline below the standard value The lack of noradrenaline will lead to the inability to maintain sufficient blood pressure and blood flow to the brain when standing upright The frequent occurrence of noradrenaline deficiency will lead to dizziness, blurred vision, fatigue, inattention and fainting Between 800000 and 150000 people in the United States suffer from the disease Northern a was approved through the FDA accelerated approval process Original link: http://www.rttnews.com/2271561/chelsea-therapeutics-gets-accelerated-fda-approval-for-northern.aspx
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.